,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,747,1,1,,24714979,838,Unspecified,4885617.0,6783.0,,,Basic StarGazer Assay on Human SULT1E1,Other,,
1,2062,1,2,,85209584,838,Active,,,,,Ligands of bioamine (Class A) GPCRs,Other,,
2,2660,1,1,,90341754,838,Inactive,4826730.0,2475.0,,Potency,"Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
3,2666,1,1,,90341754,838,Inactive,4826730.0,2475.0,,Potency,"High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
4,2667,1,1,,90341754,838,Inactive,4826730.0,2475.0,,Potency,High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells,Confirmatory,,
5,2668,1,1,,90341754,838,Inactive,4826730.0,2475.0,,Potency,Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells,Confirmatory,,
6,463106,1,2,,90341754,838,Inactive,188528692.0,9099.0,,Potency,qHTS Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
7,485295,1,2,,90341754,838,Inactive,30027657.0,,,Potency,qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria,Confirmatory,,
8,485297,1,1,,90341754,838,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
9,485298,1,1,,90341754,838,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
10,485313,1,2,,90341754,838,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
11,485342,1,2,,90341754,838,Inactive,5454140.0,7251.0,,Potency,qHTS Validation Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
12,485345,1,2,,90341754,838,Inconclusive,,,,Potency,qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
13,485366,1,2,,90341754,838,Inconclusive,4501969.0,154.0,1.2995,Potency,qHTS validation assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
14,485368,1,2,,90341754,838,Inactive,72386991.0,3656265.0,,Potency,qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
15,488772,1,1,,90341754,838,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
16,488773,1,2,,90341754,838,Inconclusive,8659577.0,58819.0,5.9728,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
17,488816,1,1,,90341754,838,Inconclusive,4758356.0,2237.0,3.3587,Potency,qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1),Confirmatory,,
18,488837,1,1,,90341754,838,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
19,488949,1,2,,90341754,838,Inactive,41055989.0,54737.0,,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
20,488953,1,1,,90341754,838,Inactive,187960037.0,10951.0,,Potency,qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
21,488978,1,1,,90341754,838,Inactive,45359078.0,,,Potency,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity: MmCpn Primary Screen,Confirmatory,,
22,488981,1,1,,90341754,838,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Agonists,Confirmatory,,
23,488982,1,1,,90341754,838,Inactive,4503383.0,1812.0,1.8355,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Potentiators,Confirmatory,,
24,488983,1,1,,90341754,838,Active,4503383.0,1812.0,3.9811,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists,Confirmatory,,
25,493106,1,1,,90341754,838,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
26,493107,1,1,,90341754,838,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
27,493153,1,1,,90341754,838,Inactive,,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
28,493153,1,1,,90341754,838,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
29,493164,1,2,,90341754,838,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
30,493164,1,2,,90341754,838,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
31,493164,1,2,,90341754,838,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
32,504327,1,1,,90341754,838,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
33,504332,1,1,,90341754,838,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
34,504536,1,1,,90341754,838,Inactive,5453898.0,5300.0,26.8545,Potency,qHTS Validation Assay to Find Inhibitors of Pin1,Confirmatory,,
35,504547,1,1,,90341754,838,Inactive,115503961.0,4357161.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
36,504548,1,2,,90341754,838,Inactive,157877932.0,5655980.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Mutase,Confirmatory,,
37,504810,1,2,,90341754,838,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
38,504812,1,2,,90341754,838,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
39,504836,1,2,,90341754,838,Inactive,168984549.0,,,Potency,Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation,Confirmatory,11836247.0,
40,504845,1,1,,90341754,838,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
41,504847,1,1,,90341754,838,Inconclusive,63054845.0,7421.0,89.1251,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
42,504865,1,1,,90341754,838,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
43,540256,1,2,,90341754,838,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
44,540276,1,2,,50111067,838,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
45,540276,1,2,,90341754,838,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
46,588349,1,1,,90341754,838,Inconclusive,,,39.8107,Potency,qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay,Confirmatory,,
47,588378,1,1,,90341754,838,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression: Validation,Confirmatory,,
48,588453,1,1,,90341754,838,Inconclusive,8659577.0,58819.0,5.9728,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
49,588456,1,1,,90341754,838,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
50,588579,1,1,,90341754,838,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
51,588795,1,1,,90341754,838,Inconclusive,4758356.0,2237.0,3.3587,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
52,602332,1,1,,90341754,838,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
53,624146,1,1,,90341754,838,Inactive,71051501.0,2744.0,5.6234,Potency,qHTS for Inhibitors of Glutaminase (GLS): LOPAC Validation,Confirmatory,,
54,624147,1,1,,90341754,838,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors: LOPAC Validation,Confirmatory,,
55,624148,1,2,,90341754,838,Inconclusive,1724069.0,2740.0,2.3109,Potency,qHTS of GLP-1 Receptor Agonists: LOPAC Validation,Confirmatory,,
56,624149,1,1,,90341754,838,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators: LOPAC Validation,Confirmatory,,
57,624349,1,2,,121362391,838,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
58,624455,1,1,,90341754,838,Active,299681.0,1812.0,0.3264,Potency,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF,Confirmatory,,
59,651635,1,3,,90341754,838,Inconclusive,171543895.0,6311.0,39.8107,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
60,651828,1,2,,121362391,838,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
61,652106,1,1,,90341754,838,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
62,720538,1,2,,90341754,838,Inconclusive,220983390.0,410.0,30.1313,Potency,qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay,Confirmatory,,
63,720554,1,3,,121362391,838,Inactive,52423132.0,3087402.0,,,Inhibition of the Burkholderia mallei acyl-homoserine lactone synthase BmaI1,Other,,
64,720559,1,2,,90341754,838,Inactive,112927.0,351.0,,Potency,qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay,Confirmatory,,
65,720572,1,2,,90341754,838,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (NLuc Reporter),Confirmatory,,
66,720573,1,2,,90341754,838,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (FLuc Reporter),Confirmatory,,
67,743205,1,1,,90341754,838,Inactive,4503951.0,2645.0,0.631,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
68,743205,1,1,,90341754,838,Inactive,221625433.0,2646.0,0.631,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
69,743206,1,1,,90341754,838,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
70,743206,1,1,,90341754,838,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
71,743207,1,1,,90341754,838,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
72,743207,1,1,,90341754,838,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
73,743244,1,1,,90341754,838,Inconclusive,,,5.6234,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
74,743268,1,1,,172080794,838,Inactive,,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors of the NIH Clinical Collection: biochemical high-throughput screening assay to identify compounds that enhance or quench fluorescence of a Cy5-labeled substrate oligonucliotide bound to E. coli SSB,Screening,,
75,743270,1,1,,172080794,838,Inactive,125541954.0,,,,Fluorescence polarization based primary biochemical high throughput screening  assay of the NIH Clinical Collections to identify inhibitors of hepatitis C non-structural protein 3 helicase,Screening,,
76,743271,1,1,,172080794,838,Inactive,,,,,Biochemical high throughput counterscreening assay of the NIH Clinical Collection for inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3): fluorescence polarization based assay to identify compounds that can displace E. coli single stranded binding protein,Screening,,
77,743272,1,1,,172080794,838,Inactive,,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors of the NIH Clinical Collection: a biochemical high-throughput screening assay to identify compounds that cause fluorescent interference,Screening,,
78,929015,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S040818,Other,,
79,929016,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S040818,Other,,
80,929017,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S040818,Other,,
81,929018,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S040818,Other,,
82,929019,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S040818,Other,,
83,929020,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S040818,Other,,
84,930083,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S040818,Other,,
85,930084,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S040818,Other,,
86,930085,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S040818,Other,,
87,930086,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S040818,Other,,
88,930087,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S040818,Other,,
89,930088,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S040818",Other,,
90,930089,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S040818,Other,,
91,930090,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S040818,Other,,
92,930091,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S040818,Other,,
93,930720,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S040818,Other,,
94,930721,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S040818,Other,,
95,930722,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S040818,Other,,
96,930723,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S040818,Other,,
97,930724,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S040818,Other,,
98,930725,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S040818,Other,,
99,930726,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S040818,Other,,
100,930727,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S040818,Other,,
101,930728,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S040818,Other,,
102,930729,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S040818,Other,,
103,931036,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S040818,Other,,
104,931037,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S040818,Other,,
105,931038,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S040818,Other,,
106,931039,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S040818,Other,,
107,931040,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S040818,Other,,
108,931041,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S040818,Other,,
109,931042,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S040818,Other,,
110,931043,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S040818,Other,,
111,931044,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S040818,Other,,
112,931045,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S040818",Other,,
113,931046,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S040818,Other,,
114,931047,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S040818,Other,,
115,931048,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S040818,Other,,
116,939305,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S040818,Other,,
117,941953,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S040818",Other,,
118,941954,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S040818,Other,,
119,941955,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S040818,Other,,
120,941956,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S040818,Other,,
121,941957,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S040818,Other,,
122,941958,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S040818,Other,,
123,941959,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S040818,Other,,
124,941960,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S040818,Other,,
125,941961,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S040818,Other,,
126,941962,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S040818,Other,,
127,941963,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S040818,Other,,
128,941964,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S040818,Other,,
129,941965,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S040818,Other,,
130,941966,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S040818,Other,,
131,941967,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S040818,Other,,
132,941968,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S040818,Other,,
133,941969,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S040818,Other,,
134,941970,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S040818,Other,,
135,957312,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S040818,Other,,
136,957313,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S040818,Other,,
137,957314,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S040818,Other,,
138,957315,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S040818,Other,,
139,957316,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S040818,Other,,
140,957317,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S040818,Other,,
141,957318,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S040818,Other,,
142,957319,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S040818,Other,,
143,957320,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S040818,Other,,
144,957321,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S040818,Other,,
145,957322,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S040818,Other,,
146,959189,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S040818,Other,,
147,959190,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S040818,Other,,
148,959191,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S040818,Other,,
149,959192,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S040818,Other,,
150,959193,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S040818,Other,,
151,959194,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S040818,Other,,
152,959195,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S040818,Other,,
153,964970,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S040818,Other,,
154,964971,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S040818,Other,,
155,964972,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S040818,Other,,
156,964973,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S040818,Other,,
157,964974,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S040818,Other,,
158,964975,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S040818,Other,,
159,964976,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S040818,Other,,
160,964977,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S040818,Other,,
161,964978,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S040818,Other,,
162,964979,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S040818,Other,,
163,964980,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S040818,Other,,
164,964981,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S040818,Other,,
165,964982,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S040818,Other,,
166,964983,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S040818,Other,,
167,964984,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S040818,Other,,
168,964985,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S040818,Other,,
169,964986,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S040818,Other,,
170,965386,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S040818,Other,,
171,969092,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S040818,Other,,
172,969093,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S040818,Other,,
173,969094,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S040818,Other,,
174,969095,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S040818,Other,,
175,969096,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S040818,Other,,
176,969097,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S040818,Other,,
177,969098,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S040818,Other,,
178,971121,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S040818,Other,,
179,971122,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S040818,Other,,
180,971123,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S040818,Other,,
181,971124,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S040818,Other,,
182,971125,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S040818,Other,,
183,971126,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S040818,Other,,
184,971127,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S040818,Other,,
185,971128,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S040818,Other,,
186,971759,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S040818,Other,,
187,971760,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S040818,Other,,
188,971761,1,3,,160671800,838,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S040818,Other,,
189,996748,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Cellular Infiltrate, Mononuclear Cell; Study_ID: S040818",Other,,
190,996749,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Necrosis, Fibrinoid; Study_ID: S040818",Other,,
191,997333,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Perivascular Fibrosis; Study_ID: S040818",Other,,
192,997334,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Cellular Infiltrate, Mononuclear Cell; Study_ID: S040818",Other,,
193,997335,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Myocyte, Degeneration; Study_ID: S040818",Other,,
194,997336,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Cellular Infiltrate, Mononuclear Cell; Study_ID: S040818",Other,,
195,997337,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Papillary Muscle, Cellular Infiltrate, Mononuclear Cell; Study_ID: S040818",Other,,
196,997338,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Endocardium, Cellular Infiltrate, Mononuclear Cell; Study_ID: S040818",Other,,
197,997339,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Tunica Media, Hypertrophy; Study_ID: S040818",Other,,
198,997340,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Left Atrium, Myocyte, Degeneration; Study_ID: S040818",Other,,
199,997341,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Cellular Infiltrate, Mixed Cell; Study_ID: S040818",Other,,
200,997342,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Cellular Infiltrate, Mixed Cell; Study_ID: S040818",Other,,
201,997343,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Fibrosis; Study_ID: S040818",Other,,
202,997344,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Myocyte, Degeneration; Study_ID: S040818",Other,,
203,997345,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Cellular Infiltrate, Mixed Cell; Study_ID: S040818",Other,,
204,1002099,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Epicardium, Cellular Infiltrate, Mixed Cell; Study_ID: S040818",Other,,
205,1002100,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Epicardium, Cellular Infiltrate, Mononuclear Cell; Study_ID: S040818",Other,,
206,1002101,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Left Atrium, Fibrosis; Study_ID: S040818",Other,,
207,1002102,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Papillary Muscle, Myocyte, Degeneration; Study_ID: S040818",Other,,
208,1002103,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Cellular Infiltrate, Mononuclear Cell; Study_ID: S040818",Other,,
209,1002104,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Fibrosis; Study_ID: S040818",Other,,
210,1002105,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Cellular Infiltrate, Mixed Cell; Study_ID: S040818",Other,,
211,1002106,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Left Atrium, Cellular Infiltrate, Mononuclear Cell; Study_ID: S040818",Other,,
212,1002107,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Myocyte, Degeneration; Study_ID: S040818",Other,,
213,1002108,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Myocyte, Lipid Accumulation; Study_ID: S040818",Other,,
214,1002109,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Degeneration; Study_ID: S040818",Other,,
215,1002110,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Perivascular Edema; Study_ID: S040818",Other,,
216,1002111,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Fibrosis; Study_ID: S040818",Other,,
217,1002112,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Papillary Muscle, Cellular Infiltrate, Mixed Cell; Study_ID: S040818",Other,,
218,1002113,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Right Atrium, Cellular Infiltrate, Mononuclear Cell; Study_ID: S040818",Other,,
219,1002114,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Epicardium, Hyperplasia; Study_ID: S040818",Other,,
220,1010009,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Left Atrium, Cellular Infiltrate, Mononuclear Cell; Study_ID: S040818",Other,,
221,1010010,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Myocyte, Degeneration; Study_ID: S040818",Other,,
222,1010011,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Myocyte, Lipid Accumulation; Study_ID: S040818",Other,,
223,1010012,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Degeneration; Study_ID: S040818",Other,,
224,1010013,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Perivascular Edema; Study_ID: S040818",Other,,
225,1010014,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Fibrosis; Study_ID: S040818",Other,,
226,1010015,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Papillary Muscle, Cellular Infiltrate, Mixed Cell; Study_ID: S040818",Other,,
227,1010016,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Right Atrium, Cellular Infiltrate, Mononuclear Cell; Study_ID: S040818",Other,,
228,1010017,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Epicardium, Hyperplasia; Study_ID: S040818",Other,,
229,1010018,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Cellular Infiltrate, Mononuclear Cell; Study_ID: S040818",Other,,
230,1010019,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Necrosis, Fibrinoid; Study_ID: S040818",Other,,
231,1010020,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Perivascular Fibrosis; Study_ID: S040818",Other,,
232,1010021,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Cellular Infiltrate, Mononuclear Cell; Study_ID: S040818",Other,,
233,1010022,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Myocyte, Degeneration; Study_ID: S040818",Other,,
234,1010023,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Cellular Infiltrate, Mononuclear Cell; Study_ID: S040818",Other,,
235,1010024,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Papillary Muscle, Cellular Infiltrate, Mononuclear Cell; Study_ID: S040818",Other,,
236,1010025,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Endocardium, Cellular Infiltrate, Mononuclear Cell; Study_ID: S040818",Other,,
237,1010026,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Tunica Media, Hypertrophy; Study_ID: S040818",Other,,
238,1010027,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Left Atrium, Myocyte, Degeneration; Study_ID: S040818",Other,,
239,1010028,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Cellular Infiltrate, Mixed Cell; Study_ID: S040818",Other,,
240,1010029,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Cellular Infiltrate, Mixed Cell; Study_ID: S040818",Other,,
241,1010030,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Fibrosis; Study_ID: S040818",Other,,
242,1010031,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Interventricular Septum, Myocyte, Degeneration; Study_ID: S040818",Other,,
243,1010032,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Left Ventricle, Cellular Infiltrate, Mixed Cell; Study_ID: S040818",Other,,
244,1012473,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Epicardium, Cellular Infiltrate, Mixed Cell; Study_ID: S040818",Other,,
245,1012474,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Epicardium, Cellular Infiltrate, Mononuclear Cell; Study_ID: S040818",Other,,
246,1012475,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Left Atrium, Fibrosis; Study_ID: S040818",Other,,
247,1012476,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Papillary Muscle, Myocyte, Degeneration; Study_ID: S040818",Other,,
248,1012477,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Cellular Infiltrate, Mononuclear Cell; Study_ID: S040818",Other,,
249,1012478,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Right Ventricle, Fibrosis; Study_ID: S040818",Other,,
250,1012479,1,3,,160671800,838,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: mini-pump - subcutaneous | Dataset: Pathology; Tissue: Heart; Assay: Intramyocardial Arteries, Cellular Infiltrate, Mixed Cell; Study_ID: S040818",Other,,
251,1159580,2,1,,268738141,838,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
252,1159607,2,1,,312310307,838,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
253,1224859,2,1,,90341754,838,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
254,1259310,1,1,,104170169,838,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
255,1259325,1,2,,336956310,838,Inactive,4504843.0,3763.0,,,Discovering small molecule activators of G protein-gated inwardly-rectifying potassium subunit 2 (GIRK2) containing channels utilizing methyl-2 4-pentanediol (MPD) for partial channel activation during screening,Screening,,
256,1259406,1,1,,363920225,838,Unspecified,,,,,BK Channel Variant Modulator Selectivity Assay,Screening,,
257,1259406,1,1,1.0,363920225,838,Inactive,26638650.0,3778.0,-0.022254,LogChange(F380Y),BK Channel Variant Modulator Selectivity Assay,Screening,,
258,1259406,1,1,2.0,363920225,838,Inactive,4758626.0,3779.0,-0.024791099999999996,LogChange(F380Y/beta1),BK Channel Variant Modulator Selectivity Assay,Screening,,
259,1259406,1,1,3.0,363920225,838,Inactive,5031823.0,10242.0,0.0366967,LogChange(F380Y/beta2Delta),BK Channel Variant Modulator Selectivity Assay,Screening,,
260,1259406,1,1,4.0,363920225,838,Inactive,26051275.0,27345.0,-0.00840449,LogChange(F380Y/beta4),BK Channel Variant Modulator Selectivity Assay,Screening,,
261,1259406,1,1,5.0,363920225,838,Inactive,160410009.0,389816.0,0.0502947,LogChange(F380Y/Slo1WT/gamma1),BK Channel Variant Modulator Selectivity Assay,Screening,,
262,1259406,1,1,6.0,363920225,838,Inactive,26638650.0,3778.0,0.039869999999999996,LogChange(R275C),BK Channel Variant Modulator Selectivity Assay,Screening,,
263,1259406,1,1,7.0,363920225,838,Inactive,4758626.0,3779.0,-0.0202696,LogChange(R275C/beta1),BK Channel Variant Modulator Selectivity Assay,Screening,,
264,1259406,1,1,8.0,363920225,838,Inactive,5031823.0,10242.0,-0.0287019,LogChange(R275C/beta2Delta),BK Channel Variant Modulator Selectivity Assay,Screening,,
265,1259406,1,1,9.0,363920225,838,Inactive,26051275.0,27345.0,-0.031251,LogChange(R275C/beta4),BK Channel Variant Modulator Selectivity Assay,Screening,,
266,1259406,1,1,10.0,363920225,838,Inactive,5031823.0,10242.0,-0.0974217,LogChange(R275C/Slo1WT/beta2),BK Channel Variant Modulator Selectivity Assay,Screening,,
267,1259407,1,1,,363906090,838,Inactive,,,,,CCRIS mutagenicity studies,Other,,
268,1259413,1,2,,104170169,838,Inactive,47605623.0,173990.0,,,Modulators of fzo-1,Other,,
269,1259423,1,2,,354784745,838,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
270,1259423,1,2,,354924994,838,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
271,1259423,1,2,,355017456,838,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
272,1259426,1,2,,354784745,838,Active,550600288.0,5570400.0,0.327,EC50_MICROM,Counter Screen to Identify Specific Small molecule Agonists for Aedes aegypti NPYLR7 Receptor,Confirmatory,,
273,1259427,1,2,,354784745,838,Inactive,,,0.706,EC50_MICROM,Hit Validation Assay to Identify small molecule Aedes aegypti NPYLR7 Agonists [Small Molecule Inhibitors of Mosquito Biting Behavior],Confirmatory,,
